"The results of STORM CHASER suggest that AZD7442 may be useful in preventing symptomatic COVID-19 in individuals not already infected," Myron J. Levin, M.D., professor of pediatrics and medicine at University of Colorado School of Medicine, and principal trial investigator, said in a news release.